Viewing Study NCT05025033


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-01-09 @ 5:37 AM
Study NCT ID: NCT05025033
Status: COMPLETED
Last Update Posted: 2023-01-18
First Post: 2021-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Chemotherapy Combined With Apatinib and PD-1 Antibody
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gastric cancer View
None second-line treatment View
None chemotherapy View
None Apatinib mesylate View
None immunotherapy View
None PD-1 antibody View